Design and characterization of mouse IgG1 and IgG2a bispecific antibodies for use in syngeneic models

Feng Wanga Protein Therapeutics and Biologics Lead Discovery, Bristol-Myers Squibb, Redwood City, CA, USA

Jordan C. Tsaia Protein Therapeutics and Biologics Lead Discovery, Bristol-Myers Squibb, Redwood City, CA, USA

Jonathan H. Davisb Invenra, Inc, Madison, WI, USA

Bryant Chaua Protein Therapeutics and Biologics Lead Discovery, Bristol-Myers Squibb, Redwood City, CA, USA

Jia Donga Protein Therapeutics and Biologics Lead Discovery, Bristol-Myers Squibb, Redwood City, CA, USA

Sean M. Westa Protein Therapeutics and Biologics Lead Discovery, Bristol-Myers Squibb, Redwood City, CA, USA

Jason M. Hogana Protein Therapeutics and Biologics Lead Discovery, Bristol-Myers Squibb, Redwood City, CA, USA

Matthew L. Wheelerc Immuno-Oncology Research, Bristol-Myers Squibb, Redwood City, CA, USA

Christine Beea Protein Therapeutics and Biologics Lead Discovery, Bristol-Myers Squibb, Redwood City, CA, USA

Winse Morishigea Protein Therapeutics and Biologics Lead Discovery, Bristol-Myers Squibb, Redwood City, CA, USA

Thomas Caytona Protein Therapeutics and Biologics Lead Discovery, Bristol-Myers Squibb, Redwood City, CA, USA

Donata David-brownd Bioanalytical Sciences, Bristol-Myers Squibb, Princeton, NJ, USA

Chengyue Zhange Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Redwood City, CA, USA

Alexander Kozhichd Bioanalytical Sciences, Bristol-Myers Squibb, Princeton, NJ, USA

Tim Sproula Protein Therapeutics and Biologics Lead Discovery, Bristol-Myers Squibb, Redwood City, CA, USA

Gavin Dollingera Protein Therapeutics and Biologics Lead Discovery, Bristol-Myers Squibb, Redwood City, CA, USA

Arvind Rajpala Protein Therapeutics and Biologics Lead Discovery, Bristol-Myers Squibb, Redwood City, CA, USA

Pavel Stropa Protein Therapeutics and Biologics Lead Discovery, Bristol-Myers Squibb, Redwood City, CA, USACorrespondence[email protected]

Articles from other publishers (9)